This suggests that while SSI-(1-4) require the presence of SCD1 to produce anti-tumor effects, their potencies are likely dependent on multiple factors beyond the simple expression levels of the enzyme, such as the presence of compensatory mechanisms for fatty acid metabolism [33]. The gene discussed is SCD; the disease is neoplasm.